title: Leukotriene B4 triggers highly characteristic and specific functional responses in neutrophils: studies of stimulus specific mechanisms.
abstract: By using human neutrophils we studied the on-off phenomenon for leukotriene B4 (LTB4) -induced functional responses compared with fMetLeuPhe (fMLP). LTB4 induced rapidly appearing and disappearing neutrophil chemiluminescent (CL), superoxide anion formation, aggregatory and membrane depolarizing responses, whereas fMLP responses were slower both in onset and termination. Increases of intracellular calcium concentrations (as reflected by quin2 and fura-2 fluorescence) were of similar magnitude for both stimuli; however, LTB4 responses were more rapidly terminated and fMLP responses were biphasic. When intracellular calcium fluxes, calmodulin or protein kinase C activities were inhibited by quin2, trifluoperazine, verapamil or 3,4,5-trimethoxybenzoic acid 8-diethylamino)octyl ester (TMB-8), profound changes were noted for chemiluminescent and aggregation kinetics induced by fMLP, whereas kinetics of LTB4 responses were less affected. When drugs were used to modulate cAMP levels, or to inhibit cyclo- and lipoxygenase metabolites of arachidonic acid, no effects on response kinetics were observed. Cytochalasin B both amplified and delayed responses although chemiluminescent responses to fMLP were amplified more than those to LTB4. Despite those effects cytochalasin B did not enhance peak fura-2 or quin2 responses to either fMLP or LTB4. Thus, LTB4 rapidly initiates functional responses in neutrophils, and stimulus-specific response patterns are already discernable during the mobilization of calcium, and can be modulated by interference with calcium-dependent reactions.
authors: Department of Medicine III, Karolinska Institute, Stockholm, Sweden.
authors: J
authors: J
authors: Palmblad
authors: H
authors: H
authors: Gyllenhammar
authors: B
authors: B
authors: Ringertz
authors: E
authors: E
authors: Nilsson
authors: B
authors: B
authors: Cottell
mesh_terms: D000634:Aminoquinolines; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001572:Benzofurans; D000001:Calcimycin; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003599:Cytoskeleton / Q000378:metabolism; D016257:Fura-2; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D007700:Kinetics; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D008163:Luminescent Measurements; D008564:Membrane Potentials / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D013481:Superoxides / Q000378:metabolism
chemical_list: D000634:Aminoquinolines; D001095:Arachidonic Acids; D001572:Benzofurans; D007473:Ion Channels; D013481:Superoxides; D007975:Leukotriene B4; D016718:Arachidonic Acid; D000001:Calcimycin; D000242:Cyclic AMP; C035739:Quin2; D002118:Calcium; D016257:Fura-2